STOCK TITAN
  1. Home
  2. Sec-filings
  3. AKYA
  4. [EFFECT] Akoya BioSciences, Inc. SEC Filing

[EFFECT] Akoya BioSciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025
Accession Number: 0001104659-25-066357
Submission Type: POS AM
CIK: 0001711933
Company Name: Akoya Biosciences, Inc.
File Number: 333-268214

Source: View Original Filing on SEC EDGAR

Stock AKYA logo
Akoya Biosciences, Inc.

NASDAQ:AKYA

AKYA Rankings

#5089 Ranked by Market Cap
N/A Ranked by Dividends

AKYA Latest News

May 23, 2025
Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal
May 12, 2025
Akoya Biosciences Reports First Quarter 2025 Financial Results
May 7, 2025
NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia
Apr 30, 2025
Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders
Apr 29, 2025
Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA Latest SEC Filings

Jul 18, 2025
[15-12G] Akoya BioSciences, Inc. SEC Filing
Jul 10, 2025
[Form 4] Akoya BioSciences, Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Akoya BioSciences, Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Akoya BioSciences, Inc. Insider Trading Activity
Jul 10, 2025
[Form 4] Akoya BioSciences, Inc. Insider Trading Activity

AKYA Stock Data

65.94M
25.71M
72.58%
69.8%
5.29%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States
MARLBOROUGH